Sergii Myronenko, MD

Survey sheds light on the regional-specific risks of managing clinical trial sites in Eastern Europe.

Survey of pharma and CRO clinical trial professionals attempts to answer whether Eastern European countries are still considered attractive destinations for clinical research.